Amicus Therapeutics Ownership | Who Owns Amicus Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Amicus Therapeutics Ownership Summary


Amicus Therapeutics is owned by 43.81% institutional investors, 0.71% insiders, and 55.48% retail investors. Vanguard group is the largest institutional shareholder, holding 9.59% of FOLD shares. Vanguard Health Care Inv is the top mutual fund, with 6.78% of its assets in Amicus Therapeutics shares.

FOLD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAmicus Therapeutics43.81%0.71%55.48%
SectorHealthcare Stocks 42.50%10.81%46.69%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group29.53M9.59%$232.73M
Wellington management group llp28.63M9.30%$225.60M
Blackrock funding, inc. /de25.85M8.39%$203.69M
Blackrock24.37M8.05%$241.77M
William blair investment management15.75M5.11%$124.10M
Avoro capital advisors15.03M4.88%$118.40M
State street11.56M3.75%$91.12M
Vestal point capital, lp9.75M3.17%$76.83M
Point72 asset management7.16M2.32%$56.39M
Geode capital management7.10M2.31%$55.95M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Palo alto investors lp5.37M7.83%$42.30M
Sovereign's capital management834.43K3.57%$6.58M
Vestal point capital, lp9.75M3.47%$76.83M
Prosight management, lp1.71M3.14%$13.47M
Cm management450.00K2.96%$3.55B
Iron triangle partners lp1.97M2.21%$15.53M
Soleus capital management4.69M1.86%$36.96M
Sphera funds management991.14K1.65%$7.81M
Avoro capital advisors15.03M1.53%$118.40M
Birchview capital, lp253.00K1.51%$1.99M

Top Buyers

HolderShares% AssetsChange
Soleus capital management4.69M1.86%4.69M
Point72 asset management7.16M0.09%3.88M
Norges bank3.08M0.00%3.08M
Pictet asset management sa3.91M0.02%2.28M
Iron triangle partners lp1.97M2.21%1.97M

Top Sellers

HolderShares% AssetsChange
American century companies---3.90M
Macquarie group4.56M0.04%-3.16M
Fiera capital---3.04M
Avoro capital advisors15.03M1.53%-2.98M
Janus henderson group3.40M0.02%-2.94M

New Positions

HolderShares% AssetsChangeValue
Soleus capital management4.69M1.86%4.69M$36.96M
Norges bank3.08M0.00%3.08M$29.03M
Iron triangle partners lp1.97M2.21%1.97M$15.53M
Nordea investment management ab997.78K0.01%997.78K$7.84M
Ion asset management872.41K0.76%872.41K$6.87M

Sold Out

HolderChange
Skopos labs-22.00
Capital performance advisors llp-43.00
Cva family office-43.00
Svb wealth-44.00
Innealta capital-47.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2025166-39.19%134,937,657-54.68%430.47%101-32.21%43-46.25%
Jun 30, 2025279-4.78%319,193,5204.06%1031.04%1520.66%81-3.57%
Mar 31, 2025293-2.98%309,463,7181.44%1001.00%1522.01%83-17.82%
Dec 31, 2024144-52.32%151,685,331-50.57%490.49%60-59.46%59-35.16%
Sep 30, 202430012.78%306,793,850-2.57%1000.93%1495.67%9020.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Health Care Inv20.89M6.78%-
Vanguard Total Stock Mkt Idx Inv9.51M3.08%-200.71K
Vanguard US Total Market Shares ETF9.38M3.05%10.28K
Vanguard Small Cap Index7.47M2.42%-48.88K
iShares Russell 2000 ETF6.55M2.12%-124.42K
Macquarie Small Cap Core I5.62M1.82%614.64K
Delaware Small Cap Core I5.13M1.73%-31.80K
SPDR® S&P Biotech ETF5.04M1.64%124.19K
Janus Henderson Opportunistic Alpha MA4.58M1.54%4.58M
Janus Henderson US Opportunistic Alpha4.58M1.54%-565.02K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 01, 2025Campbell Bradley L President and CEOSell$146.01K
Nov 24, 2025Castelli Jeff Chief Development OfficerSell$773.66K
Nov 24, 2025Clark David Michael Chief People OfficerSell$258.93K
Nov 24, 2025Campbell Bradley L President and CEOSell$146.52K
Nov 26, 2025Rosenberg Ellen Chief Legal OfficerSell$236.21K

Insider Transactions Trends


DateBuySell
2025 Q4-7
2025 Q3--
2025 Q2--
2025 Q1-1
2024 Q4-4

FOLD Ownership FAQ


Who Owns Amicus Therapeutics?

Amicus Therapeutics shareholders are primarily institutional investors at 43.81%, followed by 0.71% insiders and 55.48% retail investors. The average institutional ownership in Amicus Therapeutics's industry, Biotech Stocks , is 45.24%, which Amicus Therapeutics falls below.

Who owns the most shares of Amicus Therapeutics?

Amicus Therapeutics’s largest shareholders are Vanguard group (29.53M shares, 9.59%), Wellington management group llp (28.63M shares, 9.30%), and Blackrock funding, inc. /de (25.85M shares, 8.39%). Together, they hold 27.28% of Amicus Therapeutics’s total shares outstanding.

Does Blackrock own Amicus Therapeutics?

Yes, BlackRock owns 8.05% of Amicus Therapeutics, totaling 24.37M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 241.77M$. In the last quarter, BlackRock increased its holdings by 1.52M shares, a 6.66% change.

Who is Amicus Therapeutics’s biggest shareholder by percentage of total assets invested?

Palo alto investors lp is Amicus Therapeutics’s biggest shareholder by percentage of total assets invested, with 7.83% of its assets in 5.37M Amicus Therapeutics shares, valued at 42.3M$.

Who is the top mutual fund holder of Amicus Therapeutics shares?

Vanguard Health Care Inv is the top mutual fund holder of Amicus Therapeutics shares, with 6.78% of its total shares outstanding invested in 20.89M Amicus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools